{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:34:58Z","timestamp":1786980898706,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,2,26]],"date-time":"2009-02-26T00:00:00Z","timestamp":1235606400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s10620-009-0723-6","type":"journal-article","created":{"date-parts":[[2009,2,25]],"date-time":"2009-02-25T15:33:52Z","timestamp":1235576032000},"page":"1284-1291","source":"Crossref","is-referenced-by-count":57,"title":["Atypical Antipsychotic Quetiapine in the Management of Severe Refractory Functional Gastrointestinal Disorders"],"prefix":"10.1007","volume":"54","author":[{"given":"Madhusudan","family":"Grover","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer D.","family":"Dorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan R.","family":"Weinland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine B.","family":"Dalton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley N.","family":"Gaynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas A.","family":"Drossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,2,26]]},"reference":[{"key":"723_CR1","first-page":"295","volume-title":"Rome III: The Functional Gastrointestinal Disorders","author":"F Creed","year":"2006","unstructured":"Creed F, Levy R, Bradley L, et al. Psychosocial aspects of functional gastrointestinal disorders. In: Drossman DA, Corazziari E, Delvaux M, et al., eds. Rome III: The Functional Gastrointestinal Disorders. McLean, VA: Degnon Associates Inc.; 2006:295\u2013368."},{"key":"723_CR2","first-page":"678","volume":"2","author":"SM Thiwan","year":"2006","unstructured":"Thiwan SM, Drossman DA. Treatment of functional GI disorders with psychotropic medicines: a review of evidence with a practical approach. Gastroenterol Hepatol. 2006;2:678\u2013688.","journal-title":"Gastroenterol Hepatol"},{"issue":"12","key":"723_CR3","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMoa052964","volume":"354","author":"MH Trivedi","year":"2006","unstructured":"Trivedi MH, Fava M, Wisniewski SR, et al. Medication augmentation after the failure of SSRIs for depression. N Engl J Med. 2006;354(12):1243\u20131252. doi: 10.1056\/NEJMoa052964 .","journal-title":"N Engl J Med"},{"key":"723_CR4","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S1542-3565(05)00157-6","volume":"3","author":"A Lembo","year":"2005","unstructured":"Lembo A, Ameen V, Drossman DA. Irritable bowel syndrome: toward an understanding of severity. Clin Gastroenterol Hepatol. 2005;3:717\u2013725. doi: 10.1016\/S1542-3565(05)00157-6 .","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"Supp 8","key":"723_CR5","first-page":"38","volume":"62","author":"RB Lydiard","year":"2001","unstructured":"Lydiard RB. Irritable bowel syndrome, anxiety, and depression: what are the links? J Clin Psychiatry. 2001;62(Supp 8):38\u201345. discussion 46\u201347.","journal-title":"J Clin Psychiatry"},{"key":"723_CR6","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/sleep\/26.6.747","volume":"26","author":"AY Rotem","year":"2003","unstructured":"Rotem AY, Sperber AD, Krugliak P, Freidman B, Tal A, Tarasiuk A. Polysomnographic and actigraphic evidence of sleep fragmentation in patients with irritable bowel syndrome. Sleep. 2003;26:747\u2013752.","journal-title":"Sleep"},{"issue":"4","key":"723_CR7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1526-4637.2004.04054.x","volume":"5","author":"DA Fishbain","year":"2004","unstructured":"Fishbain DA, Cutler RB, Lewis J, Cole B, Rosomoff RS, Rosomoff HL. Do the second-generation \u201catypical neuroleptics\u201d have analgesic properties? A structured evidence-based review. Pain Med. 2004;5(4):359\u2013365. doi: 10.1111\/j.1526-4637.2004.04054.x .","journal-title":"Pain Med"},{"key":"723_CR8","volume-title":"Research Design. Qualitative, Quantitative and Mixed Methods Approaches","author":"JW Creswell","year":"2003","unstructured":"Creswell JW. Research Design. Qualitative, Quantitative and Mixed Methods Approaches. 2nd ed. California: Sage Publications; 2003.","edition":"2"},{"issue":"1","key":"723_CR9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0016-5085(03)00669-3","volume":"125","author":"DA Drossman","year":"2003","unstructured":"Drossman DA, Toner BB, Whitehead WE, et al. Cognitive behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology. 2003;125(1):19\u201331. doi: 10.1016\/S0016-5085(03)00669-3 .","journal-title":"Gastroenterology"},{"key":"723_CR10","first-page":"1","volume-title":"Rome III: The Functional Gastrointestinal Disorders","author":"DA Drossman","year":"2006","unstructured":"Drossman DA. The functional gastrointestinal disorders and the Rome III process. In: Drossman DA, Corazziari E, Delvaux M, et al., eds. Rome III: The Functional Gastrointestinal Disorders. McLean, VA: Degnon Associates Inc.; 2006:1\u201329."},{"key":"723_CR11","first-page":"487","volume-title":"Rome III: The Functional Gastrointestinal Disorders","author":"G Longstreth","year":"2006","unstructured":"Longstreth G, Thompson W, Chey W, Houghton L, et al. Functional bowel disorders. In: Drossman DA, Corazziari E, Delvaux M, Spiller RC, Talley NJ, Thompson WG, et al., eds. Rome III: The Functional Gastrointestinal Disorders. McLean, VA: Degnon Associates Inc.; 2006:487\u2013555."},{"issue":"10","key":"723_CR12","doi-asserted-by":"crossref","first-page":"782","DOI":"10.7326\/0003-4819-123-10-199511150-00007","volume":"123","author":"DA Drossman","year":"1995","unstructured":"Drossman DA, Talley NJ, Leserman J, Olden KW, Barreiro MA. Sexual and physical abuse and gastrointestinal illness. Review and recommendations. Ann Intern Med. 1995;123(10):782\u2013794.","journal-title":"Ann Intern Med"},{"issue":"2","key":"723_CR13","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1053\/j.gastro.2007.11.011","volume":"134","author":"Y Ringel","year":"2008","unstructured":"Ringel Y, Drossman DA, Leserman JL, et al. Effect of abuse history on pain reports and brain responses to aversive visceral stimulation: an FMRI study. Gastroenterology. 2008;134(2):396\u2013404. doi: 10.1053\/j.gastro.2007.11.011 .","journal-title":"Gastroenterology"},{"key":"723_CR14","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1053\/gast.2002.32392","volume":"122","author":"WE Whitehead","year":"2002","unstructured":"Whitehead WE, Palsson O, Jones KR. Systematic review of comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology. 2002;122:1140\u20131156. doi: 10.1053\/gast.2002.32392 .","journal-title":"Gastroenterology"},{"issue":"4","key":"723_CR15","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/j.1572-0241.2000.01936.x","volume":"95","author":"DA Drossman","year":"2000","unstructured":"Drossman DA, Whitehead WE, Toner BB, et al. What determines severity among patients with painful functional bowel disorders? Am J Gastroenterol. 2000;95(4):974\u2013980. doi: 10.1111\/j.1572-0241.2000.01936.x .","journal-title":"Am J Gastroenterol"},{"key":"723_CR16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4088\/JCP.v67n0304","volume":"67","author":"RM Hirschfeld","year":"2006","unstructured":"Hirschfeld RM, Weisler RH, Raines SR, Macfadden W, BOLDER Study Group. Quetiapine in the treatment of anxiety in patients with bipolar 1 and bipolar 2 depression: a secondary analysis from a randomized, double blind, placebo-controlled study. J Clin Psychiatry. 2006;67:355\u2013362.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"723_CR17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1176\/appi.psy.45.1.17","volume":"45","author":"DJ Goldstein","year":"2004","unstructured":"Goldstein DJ, Lu Y, Detke MJ, Hudson J, Iyengar S, Demitrack MA. Effects of duloxetine on painful physical symptoms associated with depression. Psychosomatics. 2004;45(1):17\u201328. doi: 10.1176\/appi.psy.45.1.17 .","journal-title":"Psychosomatics"},{"issue":"3","key":"723_CR18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00213-002-1016-3","volume":"161","author":"FI Tarazi","year":"2002","unstructured":"Tarazi FI, Zhang K, Baldessarini RJ. Long term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regions. Psychopharmacology (Berl). 2002;161(3):263\u2013270. doi: 10.1007\/s00213-002-1016-3 .","journal-title":"Psychopharmacology (Berl)"},{"key":"723_CR19","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1080\/j.1440-1614.2005.01686.x","volume":"39","author":"F Creed","year":"2005","unstructured":"Creed F, Guthurie E, Ratcliffe J, et al. Does psychosocial treatment help only those patients with severe irritable bowel syndrome who also have a concurrent psychiatric disorder? Aust N Z J Psychiatry. 2005;39:807\u2013815. doi: 10.1111\/j.1440-1614.2005.01686.x .","journal-title":"Aust N Z J Psychiatry"},{"key":"723_CR20","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1053\/j.gastro.2003.09.028","volume":"125","author":"SP Dunlop","year":"2003","unstructured":"Dunlop SP, Jenkins D, Neal KR, Spiller RC. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology. 2003;125:1651\u20131659. doi: 10.1053\/j.gastro.2003.09.028 .","journal-title":"Gastroenterology"},{"key":"723_CR21","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1053\/gast.1996.v110.pm8613034","volume":"110","author":"DA Drossman","year":"1996","unstructured":"Drossman DA, Li Z, Leserman J, Toomey TC, Hu YJ. Health status by gastrointestinal diagnosis and abuse history. Gastroenterology. 1996;110:999\u20131007. doi: 10.1053\/gast.1996.v110.pm8613034 .","journal-title":"Gastroenterology"},{"key":"723_CR22","doi-asserted-by":"crossref","first-page":"540","DOI":"10.4088\/JCP.v66n0420b","volume":"66","author":"SI Schutters","year":"2005","unstructured":"Schutters SI, van Megen HJ, Westenberg HG. Efficacy of quetiapine in generalized social anxiety disorder: results from an open label-study. J Clin Psychiatry. 2005;66:540\u2013542.","journal-title":"J Clin Psychiatry"},{"key":"723_CR23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/da.20275","volume":"24","author":"A McIntyre","year":"2007","unstructured":"McIntyre A, Gendron A, McIntyre A. Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot study. Depress Anxiety. 2007;24:487\u2013494. doi: 10.1002\/da.20275 .","journal-title":"Depress Anxiety"},{"issue":"3","key":"723_CR24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1358\/dot.1999.35.3.533849","volume":"35","author":"JM Goldstein","year":"1999","unstructured":"Goldstein JM. Quetiapine fumarate (Seroquel): a new atypical antipsychotic. Drugs Today (Barc). 1999;35(3):193\u2013210.","journal-title":"Drugs Today (Barc)"},{"key":"723_CR25","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4088\/JCP.v61n0403","volume":"61","author":"B McConville","year":"2000","unstructured":"McConville B, Arvanitis LA, Thyrum PT, et al. Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open label trial in adolescents with psychotic disorders. J Clin Psychiatry. 2000;61:252\u2013260.","journal-title":"J Clin Psychiatry"},{"key":"723_CR26","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/j.1572-0241.2000.02009.x","volume":"95","author":"R Fass","year":"2000","unstructured":"Fass R, Fullerton S, Tung S, Mayer EA. Sleep disturbances in clinic patients with functional bowel disorders. Am J Gastroenterol. 2000;95:1195\u20131200. doi: 10.1111\/j.1572-0241.2000.02009.x .","journal-title":"Am J Gastroenterol"},{"key":"723_CR27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00004714-200302000-00003","volume":"23","author":"MB Hamner","year":"2003","unstructured":"Hamner MB, Deitsch SE, Brodrick PS, Ulmer HG, Lorberbaum JP. Quetiapine treatment in patients with post traumatic stress disorder: an open trial of adjuvant therapy. J Clin Psychopharmacol. 2003;23:15\u201320. doi: 10.1097\/00004714-200302000-00003 .","journal-title":"J Clin Psychopharmacol"},{"key":"723_CR28","first-page":"421","volume":"174","author":"S Cohrs","year":"2004","unstructured":"Cohrs S, Rodenbeck A, Guan Z, et al. Sleep promoting properties of quetiapine in healthy subjects. Psychopharmacology (Berl). 2004;174:421\u2013429.","journal-title":"Psychopharmacology (Berl)"},{"key":"723_CR29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0091-3057(99)00107-0","volume":"64","author":"S Schreiber","year":"1999","unstructured":"Schreiber S, Getslev V, Backer MM. The atypical neuroleptics clozapine and olanzapine differ regarding their antipsychotic mechanisms and potency. Pharmacol Biochem Behav. 1999;64:75\u201380. doi: 10.1016\/S0091-3057(99)00107-0 .","journal-title":"Pharmacol Biochem Behav"},{"key":"723_CR30","first-page":"282","volume":"15","author":"M Shemo","year":"2003","unstructured":"Shemo M, Shemo JPD, Anderson M. Beneficial effects of quetiapine treatment in patients with fibromyalgia. J Neuropsychiatry Clin Neurosci. 2003;15:282.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"723_CR31","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0885-3924(02)00391-3","volume":"23","author":"SD Passik","year":"2002","unstructured":"Passik SD, Lundberg J, Kirsh KL, et al. A pilot exploration of the antiemetic activity of olanzapine for the relief of nausea in patients with advanced cancer and pain. J Pain Symptom Manage. 2002;23:526\u2013532. doi: 10.1016\/S0885-3924(02)00391-3 .","journal-title":"J Pain Symptom Manage"},{"key":"723_CR32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pnpbp.2006.06.023","volume":"31","author":"J Hidalgo","year":"2007","unstructured":"Hidalgo J, Rico-Villademoros F, Calandre EP. An open-label study of quetiapine in the treatment of fibromyalgia. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:71\u201377. doi: 10.1016\/j.pnpbp.2006.06.023 .","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"723_CR33","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/ard.2003.011502","volume":"63","author":"M Pimentel","year":"2004","unstructured":"Pimentel M, Wallace D, Hallegua D, et al. A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing. Ann Rheum Dis. 2004;63:450\u2013452. doi: 10.1136\/ard.2003.011502 .","journal-title":"Ann Rheum Dis"},{"key":"723_CR34","first-page":"154","volume":"29","author":"JSE Hellewell","year":"1998","unstructured":"Hellewell JSE, Hands DC, McKellar J. Seroquel: an effective atypical antipsychotic with no greater EP\u2019S than placebo across the full dose range. Schizophr Res. 1998;29:154\u2013155.","journal-title":"Schizophr Res"},{"key":"723_CR35","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/10673220500433148","volume":"13","author":"NS Brooke","year":"2005","unstructured":"Brooke NS, Wiersgalla M, Salzman C. Atypical uses of atypical antipsychotics. Harv Rev Psychiatry. 2005;13:317\u2013339. doi: 10.1080\/10673220500433148 .","journal-title":"Harv Rev Psychiatry"},{"key":"723_CR36","first-page":"636","volume-title":"Textbook of Gastroenterology, Chapter 29","author":"DA Drossman","year":"2003","unstructured":"Drossman DA, Chang L. Psychosocial factors in the care of patients with GI disorders. In: Yamada T, ed. Textbook of Gastroenterology, Chapter 29. Philadelphia: Lippincott; 2003:636\u2013654."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-009-0723-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-009-0723-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-009-0723-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T15:42:46Z","timestamp":1559230966000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-009-0723-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,26]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["723"],"URL":"https:\/\/doi.org\/10.1007\/s10620-009-0723-6","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,26]]}}}